Expanding the Treatment Landscape for Atopic Dermatitis, Hidradenitis Suppurativa, and Chronic Hand Eczema
The past 18 months has seen an unprecedented wave of FDA approvals in dermatology, significantly expanding the therapeutic options for treatment of inflammatory skin diseases. At the 2025 Skin Of Color Update in New York City, conference co-chair Dr. Andrew Alexis highlighted some of these new medications and new indications for others. Importantly, many of these pivotal clinical trials includ …
The past 18 months has seen an unprecedented wave of FDA approvals in dermatology, significantly expanding the therapeutic options for treatment of inflammatory skin diseases. At the 2025 Skin Of Color Update in New York City, conference co-chair Dr. Andrew Alexis highlighted some of these new medications and new indications for others. Importantly, many of these pivotal clinical trials includ … 
Hidradenitis suppurativa (HS) remains one of the most challenging chronic inflammatory diseases seen in dermatology. At the 2025 Skin Of Color Update conference in New York City, Dr. Tiffany Mayo led a case-based discussion on emerging therapies and management strategies for HS, with an emphasis on patients with skin of color.
HS affects between 0.1-4% of the population and is more common in … 
Last September, a co-resident and I had the opportunity to attend the annual congress of the European Academy of Dermatology and Venerology (EADV) in Amsterdam, The Netherlands. With over 17,300 attendees from over 50+ countries and a substantial contingent of “delegates” from Europe, Asia, and Africa, this was a truly diverse experience that showcased the best of dermatology from around the …